Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
The Lancet Diabetes & Endocrinology in conversation with
English - July 19, 2022 22:00 - 9 minutes - 6.69 MBLife Sciences Science Education diabetes insulin Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Rossella Nappi on menopause as a turning point for women's health
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.
Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv